SmallCaps
ASX:RAPMaterialsDiversified Metals & Mining

Raptor Metals Ltd

$0.025
$0.001 (3.85%)
Day Range
$0.025 – $0.026
Volume
181.70K
Avg Volume (10D)
662.15K
Market Cap
$9.97M

Price Chart

OHLC · volume · moving averages

$0.025-$0.025 (-50.00%)over 6M
Hi$0.059Lo$0.022
Price-sensitive newsVolumePrev close · 52W range

Market Statistics

Today's trading range

Open
$0.026
Previous Close
$0.026
Day High
$0.026
Day Low
$0.025

Valuation

Fundamental multiples

Market Cap
9.97M
Shares Outstanding
398.84M
Price to Book
1.95

Trading Activity

Volume & order book

Volume
181.70K
Value Traded
4.55K
Bid
$0.025 × 40,000
Ask
$0.027 × 169,680

Performance

Returns across timeframes

1 Day
0.00%
5 Day
-13.33%
13 Week
-46.94%

— From the desk

Latest News

ResApp Health’s takeover bid from Pfizer shaved by $53m after disappointing study results
Technology

ResApp Health’s takeover bid from Pfizer shaved by $53m after disappointing study results

ResApp Health’s (ASX: RAP) shares sank 30% this week after the company announced less than impressive study results on its COVID-19 cough detection app, which has resulted in $53 million being immediately erased from Pfizer’s proposed takeover bid. The Queensland-based digital health firm caught Pfizer’s attention in April, when a March pilot study of the […]

ResApp Health unveils at-home sleep apnoea screening app
Technology

ResApp Health unveils at-home sleep apnoea screening app

Digital health company ResApp Health (ASX: RAP) has unveiled a new smartphone app that can be used in the home to assess a person’s risk of obstructive sleep apnoea. According to ResApp, the SleepCheck app uses clinically accurate algorithms to analyse the consumer’s breathing and snoring sounds during sleep. The app does not require any […]

ResApp and Coviu team up to provide remote respiratory tests through telehealth platform
Industrials & Juniors

ResApp and Coviu team up to provide remote respiratory tests through telehealth platform

Digital health company ResApp Health (ASX: RAP) has inked a binding deal to integrate its ResAppDx-EU diagnostic test into Coviu’s telehealth platform to enable clinicians to perform respiratory assessments remotely. ResAppDx-EU is a smartphone-based acute respiratory disease diagnostic test that uses machine learning algorithms to analyse a patient’s cough sounds to diagnose lower respiratory tract […]

ResApp Health locks-in Australian TGA approval for smartphone respiratory diagnostic technology in adults
Technology

ResApp Health locks-in Australian TGA approval for smartphone respiratory diagnostic technology in adults

ResApp Health (ASX: RAP) has finally locked-in Australian Therapeutic Goods Administration for using its smartphone-based diagnostic technology to determine respiratory disease in adults. This latest milestone follows TGA approval in October to use its respiratory diagnostic technology in paediatrics. ResApp’s smartphone application ResAppDx-EU version two can now be used to diagnose respiratory disease in both […]